Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
Clinical trial NCT04037462 · TERMINATED
Trial details
- NCT number
- NCT04037462
- Sponsor
- VA Office of Research and Development
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2022-02-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.